REMUS PHARMACEUTICALS L Peer Comparison
REMUS · Healthcare · Current price ₹890
Peers tracked
11
REMUS PHARMACEUTICALS L P/E
28.4x
Sector
Healthcare
REMUS PHARMACEUTICALS L vs peers
| Company | Price | P/E | Market cap (Cr) |
|---|---|---|---|
| SUN PHARMACEUTICAL IND L | ₹1,931.7 | 39.1x | 4,63,573 |
| DIVI S LABORATORIES LTD | ₹9,220 | 69.1x | 2,44,771 |
| TORRENT PHARMACEUTICALS L | ₹5,012 | 72.9x | 1,69,673 |
| ZYDUS LIFESCIENCES LTD | ₹1,154.2 | 22.0x | 1,15,132 |
| CIPLA LTD | ₹1,412.8 | 30.3x | 1,14,112 |
| LAURUS LABS LIMITED | ₹1,864 | 92.8x | 1,00,536 |
| MANKIND PHARMA LIMITED | ₹2,391.5 | 53.7x | 98,741 |
| LUPIN LIMITED | ₹2,155.2 | 20.6x | 98,536 |
| DR. REDDY S LABORATORIES | ₹1,156.5 | 26.8x | 96,525 |
| AUROBINDO PHARMA LTD | ₹1,648.2 | 25.9x | 95,729 |
| REMUS PHARMACEUTICALS L | ₹885.3 | 23.8x | 2,252 |
REMUS PHARMACEUTICALS L versus its peers
REMUS PHARMACEUTICALS L operates in the Healthcare space alongside 11 tracked peers. Comparing valuation multiples within a sector is far more meaningful than in isolation — a P/E of 28.4x may be cheap in one industry and expensive in another.
More on REMUS PHARMACEUTICALS L
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.